Evidence method
Level · gp.fundamentals.cash
$26.8M · CORE · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
KINS · Sep 30, 2025
KINGSTONE COMPANIES, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000033992-25-000027Insurance
Evidence method
Level · gp.fundamentals.gross_debt
$4.8M · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.net_income
55.81% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.insurance.premiums
43.46% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
36.50% · CORE · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History7 statesHistory building
Period transition
What moved in the state?
- Previous
- $33.7M
- Current
- $26.8M
- Delta
- -$6.9M
- Previous
- $5.1M
- Current
- $4.8M
- Delta
- -$308,024
- Previous
- 149.22%
- Current
- 55.81%
- Delta
- -93.42%
- Previous
- 52.51%
- Current
- 43.46%
- Delta
- -9.05%
- Previous
- 43.27%
- Current
- 36.50%
- Delta
- -6.77%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · KINS Fundamental State →Has State · KINGSTONE COMPANIES, INC. →Transitioned To · KINS Fundamental State →Transitioned To · KINS CASH_DECREASED →Transitioned To · KINS DEBT_DECREASED →Transitioned To · KINS EARNINGS_GROWTH_DECREASED →Transitioned To · KINS PREMIUM_GROWTH_DECREASED →Transitioned To · KINS REVENUE_GROWTH_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.